{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:40:23Z","timestamp":1790606423831,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.neurobiolaging.2020.05.012","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T10:01:59Z","timestamp":1590919319000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories"],"prefix":"10.1016","volume":"94","author":[{"given":"Brian J.","family":"Lopresti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davneet S.","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Snitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Royse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Aizenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib3","doi-asserted-by":"crossref","first-page":"556.e13","DOI":"10.1016\/j.neurobiolaging.2010.10.020","article-title":"Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease","volume":"32","author":"Bekris","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jalz.2015.08.166","article-title":"Individual estimates of age at detectable amyloid onset for risk factor assessment","volume":"12","author":"Bilgel","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/GIM.0b013e31816b64dc","article-title":"Genetic aspects of Alzheimer disease","volume":"10","author":"Bird","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","article-title":"ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative","volume":"48","author":"Blacker","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acn3.333","article-title":"Age-dependent effects of APOE epsilon4 in preclinical Alzheimer's disease","volume":"3","author":"Bonham","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.wad.0000201854.62116.d7","article-title":"Early-life risk factors for Alzheimer disease","volume":"20","author":"Borenstein","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WAD.0b013e31816c92bf","article-title":"Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh compound-B","volume":"22","author":"Butters","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.01.015","article-title":"Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches","volume":"71","author":"Cohen","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib12","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.gene.2019.05.030","article-title":"Genetic factors associated with the predisposition to late onset Alzheimer's disease","volume":"707","author":"Durmaz","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.ATV.10.3.379","article-title":"Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study","volume":"10","author":"Eichner","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","article-title":"Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","volume":"34","author":"Fleisher","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","article-title":"Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-amyloid across the Adult life span","volume":"72","author":"Jack","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib23","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0021-9150(94)05409-C","article-title":"The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado","volume":"112","author":"Kamboh","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib26","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41598-017-02046-y","article-title":"Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: a three-year longitudinal study","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"APOE genotype and early beta-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib28","doi-asserted-by":"crossref","first-page":"e1920","DOI":"10.1212\/WNL.0000000000005549","article-title":"Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality","volume":"90","author":"Lopez","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ana.23797","article-title":"In\u00a0vivo assessment of amyloid-beta deposition in nondemented very elderly subjects","volume":"73","author":"Mathis","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2967\/jnumed.108.057612","article-title":"Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements","volume":"50","author":"McNamee","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2017.09.027","article-title":"Cortical beta-amyloid burden, gray matter, and memory in adults at varying APOE epsilon4 risk for Alzheimer's disease","volume":"61","author":"Mecca","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004728-199007000-00011","article-title":"Correction of PET data for partial volume effects in human cerebral cortex by MR imaging","volume":"14","author":"Meltzer","year":"1990","journal-title":"J.\u00a0Comput. Assist. Tomogr."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib35","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE epsilon4 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(94)12126-B","article-title":"Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians","volume":"201","author":"Morris","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib38","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/gerona\/glz088","article-title":"Association between amyloid-beta, small-vessel disease, and Neurodegeneration biomarker positivity, and progression to mild cognitive impairment in cognitively normal individuals","volume":"74","author":"Nadkarni","year":"2019","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib40","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib41","doi-asserted-by":"crossref","first-page":"e1002254","DOI":"10.1371\/journal.pmed.1002254","article-title":"APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts","volume":"14","author":"Qian","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib42","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib43","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","article-title":"Changes in Abeta biomarkers and associations with APOE genotype in 2 longitudinal cohorts","volume":"36","author":"Resnick","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-180740","article-title":"The role of apolipoprotein E isoforms in Alzheimer's disease","volume":"68","author":"Roda","year":"2019","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neuroimage.2010.12.070","article-title":"Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET","volume":"55","author":"Rosario","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","article-title":"APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway","volume":"8","author":"Sando","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib47","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib48","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03014460600594513","article-title":"APOE distribution in world populations with new data from India and the UK","volume":"33","author":"Singh","year":"2006","journal-title":"Ann. Hum. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2020.05.012_bib50","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.3233\/JAD-150113","article-title":"Amyloid-beta imaging in older adults presenting to a memory clinic with subjective cognitive decline: a Pilot study","volume":"48","author":"Snitz","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib51","first-page":"574","article-title":"Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City","volume":"58","author":"Tang","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.09.030","article-title":"Comparison of longitudinal Abeta in nondemented elderly and down syndrome","volume":"73","author":"Tudorascu","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000124750","article-title":"Distribution of APOE genotypes in a memory clinic cohort","volume":"25","author":"van der Flier","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"issue":"Pt 7","key":"10.1016\/j.neurobiolaging.2020.05.012_bib55","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","article-title":"The apolipoprotein E epsilon 2 allele and decline in episodic memory","volume":"73","author":"Wilson","year":"2002","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib57","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.1523\/JNEUROSCI.4612-13.2014","article-title":"Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden","volume":"34","author":"Wirth","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jalz.2011.07.003","article-title":"Amyloid imaging in dementias with atypical presentation","volume":"8","author":"Wolk","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib59","article-title":"Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging","author":"Yan","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.05.012_bib60","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-150446","article-title":"Subjective memory complaints in APOEvarepsilon4 carriers are associated with high amyloid-beta burden","volume":"49","author":"Zwan","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020301743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020301743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:35:38Z","timestamp":1759318538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458020301743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S0197458020301743"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.05.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}